Concepedia

Devender Dhanda

DD

Statistics

Publications

16

Citations

433

H-Index

13

Active since

2004

Affiliations

Bristol-Myers Squibb (United States)(Current)

Clinica Universidad de Navarra

Bristol-Myers Squibb (Switzerland)

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Devender Dhanda is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2004–2025

16

Publications

16

Pulmonary Delivery of Deslorelin: Large-Porous PLGA Particles and HPβCD Complexes

Kavitha Koushik, Devender Dhanda, N. Cheruvu et al. · Pharmaceutical Research · 2004 · 74 citations

Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma

Michel Delforge, Nina Shah, Jesús F. San Miguel et al. · Blood Advances · 2021 · 60 citations · Full text

Supercritical fluid technology based large porous celecoxib–PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose

Devender Dhanda, Puneet Tyagi, Sidney S. Mirvish et al. · Journal of Controlled Release · 2013 · 53 citations

, , +11

Ide-cel vs standard regimens in triple-class–exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses

Sikander Ailawadhi, Bertrand Arnulf, Krina K. Patel et al. · Blood · 2024 · 47 citations · Full text

Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Surbhi Sidana, Nausheen Ahmed, Othman Salim Akhtar et al. · Blood · 2023 · 29 citations

1–5 of 16